KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Interest & Investment Income (2016 - 2025)

Opko Health (OPK) has disclosed Interest & Investment Income for 15 consecutive years, with $3.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest & Investment Income fell 11.04% year-over-year to $3.8 million, compared with a TTM value of $14.8 million through Dec 2025, up 75.78%, and an annual FY2025 reading of $14.8 million, up 75.78% over the prior year.
  • Interest & Investment Income was $3.8 million for Q4 2025 at Opko Health, up from $3.0 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $4.7 million in Q1 2025 and bottomed at $5000.0 in Q1 2021.
  • Average Interest & Investment Income over 5 years is $1.5 million, with a median of $938000.0 recorded in 2023.
  • The sharpest move saw Interest & Investment Income tumbled 96.48% in 2021, then surged 16228.57% in 2022.
  • Year by year, Interest & Investment Income stood at $7000.0 in 2021, then soared by 16228.57% to $1.1 million in 2022, then fell by 20.73% to $906000.0 in 2023, then surged by 373.95% to $4.3 million in 2024, then dropped by 11.04% to $3.8 million in 2025.
  • Business Quant data shows Interest & Investment Income for OPK at $3.8 million in Q4 2025, $3.0 million in Q3 2025, and $3.3 million in Q2 2025.